Search
AusCann chairman Mal Washer.

Performance shares deliver windfall

The directors of medicinal cannabis companies Creso Pharma and AusCann Group Holdings have reaped windfall gains worth $13 million after the vesting of performance rights and performance shares.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BN30 Index

Index = 100 as of 4 Jan 2016
Source: Morningstar

Total Shareholder Return as at 31/01/18

1 year TSR5 year TSR
3rdAusCann Holdings13483%218%
545thHazer Group-15%0%
692ndWavenet International-40%-45%
705thSkin Elements-42%0%
804thAurora Labs-73%0%
709 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

10/05/17
$0 Other
10/05/17
$0 Issued
10/05/17
$0 Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

168th-Skin Elements$311k
169th↑Hazer Group$281k
170th↑AusCann Holdings$260k
171st↓Wavenet International$239k
172nd↑Aurora Labs$238k
234 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer